LncRNAs	Disease	Experimental methods	Regulated											Pubmed ID	Year
AGAP2-AS1	non small cell lung cancer	qRT-PCR, Western blot	H	✘	✔	✘	✘	✔	✘	✘	✘	✘	✘	32015683	2020
AGAP2-AS1	colorectal cancer	qPCR, Western blot, RIP, Luciferase reporter assay etc	H	✔	✘	✔	✘	✔	✘	✘	✘	✔	✘	32202509	2020
AGAP2-AS1	esophageal cancer	qPCR, Western blot, RIP, Luciferase reporter assay, in vitro knockdown etc	H	✘	✘	✘	✘	✘	✘	✔	✘	✔	✘	32199129	2020
AGAP2-AS1	breast cancer	qPCR, RIP, Western blot	H	✘	✔	✔	✘	✘	✘	✘	✘	✔	✘	30910994	2019
AGAP2-AS1	pancreatic cancer	qPCR, RNA-seq	H	✘	✔	✔	✘	✔	✘	✘	✘	✔	✘	30814490	2019
AGAP2-AS1	glioblastoma	qRT-PCR , Western blot , RIP etc.	H	✘	✔	✔	✘	✘	✘	✔	✘	✔	✘	31186379	2019
AGAP2-AS1	hepatocellular carcinoma	qRT-PCR , Luciferase reporter assay , Western blot , RIP , in vitro knockdown etc.	H	✘	✘	✔	✘	✔	✘	✔	✔	✔	✘	31088485	2019
AGAP2-AS1	breast cancer	qPCR, ChIP, RIP, Western blot, Fluorescence in situ hybridization analysis (FISH)	H	✔	✘	✘	✘	✘	✘	✔	✘	✔	✘	30157918	2018
AGAP2-AS1	glioma	qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, etc.	H	✘	✘	✔	✘	✘	✘	✔	✘	✔	✘	30684575	2019
AGAP2-AS1	glioblastoma	qPCRin vitro knockdown, etc.	H	✘	✘	✔	✘	✘	✘	✘	✘	✔	✘	30525219	2018
AGAP2-AS1	ovarian cancer	qPCR	H	✘	✘	✘	✘	✘	✘	✔	✘	✘	✘	31233485	2019
AGAP2-AS1	glioma	microarray, qPCR, RNAi, Flow cytometry assay, Cell proliferation assay etc.	H	✘	✘	✔	✘	✘	✘	✘	✘	✘	✘	27764782	2016
AGAP2-AS1	gastric cancer	qPCR;Western blot;etc.	H	✘	✘	✔	✘	✘	✘	✘	✘	✔	✘	28209205	2017
AGAP2-AS1	non small cell lung cancer	qPCR	H	✘	✘	✔	✘	✘	✘	✔	✘	✘	✘	28617550	2017
AGAP2-AS1	non small cell lung cancer	qPCR, RNAi, Western blot, Flow cytometry assay etc.	H	✘	✘	✔	✘	✘	✘	✘	✘	✘	✘	27195672	2016
AGAP2-AS1	Glioma	qRT-PCR,Luciferase reporter assay,Western blot,RIP	L	✘	✘	✘	✘	✘	✘	✘	✘	✔	✘	32801858	2020
AGAP2-AS1	Papillary thyroid cancer	qRT-PCR	L	✘	✘	✘	✘	✔	✘	✘	✘	✘	✘	33604734	2021
AGAP2-AS1	Breast cancer	RNA immunoprecipitation;RNA immunoprecipitation;	L	✔	✘	✘	✘	✘	✘	✘	✘	✘	✘	33273726	2021